Notably, WT-RAC1 increases SOX2 at a much-attenuated level compared to CA-RAC1 (Fig. 3F), consistent with the conclusion from MDA-MB-231 cells (Fig. 3B) that the activation is required for RAC1 to increase breast cancer cell stemness. Here, SOX2 is linked to breast cancer.